These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28293972)

  • 1. A comparison of patients' and physicians' assessments of disease activity using the Swedish version of the Systemic Lupus Activity Questionnaire.
    Pettersson S; Svenungsson E; Gustafsson J; Möller S; Gunnarsson I; Welin Henriksson E
    Scand J Rheumatol; 2017 Nov; 46(6):474-483. PubMed ID: 28293972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quick Systemic Lupus Activity Questionnaire (Q-SLAQ): a simplified version of SLAQ for patient-reported disease activity.
    Svenungsson E; Gunnarsson I; Illescas-Bäckelin V; Trysberg E; Jönsen A; Leonard D; Sjöwall C; Pettersson S
    Lupus Sci Med; 2021 May; 8(1):. PubMed ID: 33972457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Japanese version of the Systemic Lupus Activity Questionnaire that includes physician-based assessments in a large observational cohort.
    Okamoto Y; Katsumata Y; Baba S; Kawaguchi Y; Gono T; Hanaoka M; Kawasumi H; Yamanaka H
    Lupus; 2016 Apr; 25(5):486-95. PubMed ID: 26589578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies.
    Karlson EW; Daltroy LH; Rivest C; Ramsey-Goldman R; Wright EA; Partridge AJ; Liang MH; Fortin PR
    Lupus; 2003; 12(4):280-6. PubMed ID: 12729051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms.
    Askanase AD; Castrejón I; Pincus T
    J Rheumatol; 2011 Jul; 38(7):1309-16. PubMed ID: 21459938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and adaptation of the Spanish version of the systemic lupus activity questionnaire (S-SLAQ) in an Argentinean population.
    Catoggio C; Martínez Muñoz A; Chaparro Del Moral R; Klajn DS; Papasidero SB; Machado Escobar MA; Gonzalez Lucero L; Lucero E; Martinez L; Muñoz SA; Collado MV; Gomez GN; Sarano J; Marin J; Scolnik M; Romero J; Barreira JC; Zalazar MM; Rillo OL; Pisoni C
    Lupus; 2021 Dec; 30(14):2230-2236. PubMed ID: 34894851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and evaluation of the German version of the Systemic Lupus Activity Questionnaire (SLAQ).
    Chehab G; Richter J; Sander O; Fischer-Betz R; Ostendorf B; Al-Neyadi T; Vordenbäumen S; Acar H; Brinks R; Schneider M
    Clin Exp Rheumatol; 2015; 33(3):354-9. PubMed ID: 25797042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activity.
    Chang ER; Abrahamowicz M; Ferland D; Fortin PR
    J Rheumatol; 2002 Nov; 29(11):2350-8. PubMed ID: 12415591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity.
    Wolfe F; Petri M; Alarcón GS; Goldman J; Chakravarty EF; Katz RS; Karlson EW
    J Rheumatol; 2009 Jan; 36(1):82-8. PubMed ID: 19004039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
    Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR
    J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement study.
    Uhrenholt L; Høstgaard S; Pedersen JF; Christensen R; Dreyer L; Leffers HCB; Taylor PC; Strand V; Jacobsen S; Voss A; Gregersen JW; Kristensen S
    Lupus; 2021 Nov; 30(13):2124-2134. PubMed ID: 34719299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians.
    Chang E; Abrahamowicz M; Ferland D; Fortin PR;
    J Clin Epidemiol; 2002 May; 55(5):488-97. PubMed ID: 12007552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation, cultural adaptation and validation of the Systemic Lupus Erythematosus Activity Questionnaire (SLAQ) in a cohort of Italian systemic lupus erythematosus patients.
    Tani C; Vagelli R; Stagnaro C; Carli L; Lorenzoni V; Drago F; Doherty W; McSorley MR; Marconcini L; Della Rossa A; Turchetti G; Mosca M
    Lupus; 2018 Sep; 27(10):1735-1741. PubMed ID: 30045666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes.
    Rogers JL; Eudy AM; Pisetsky D; Criscione-Schreiber LG; Sun K; Doss J; Clowse MEB
    Arthritis Care Res (Hoboken); 2021 Mar; 73(3):386-393. PubMed ID: 31909888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus.
    Elefante E; Tani C; Stagnaro C; Ferro F; Parma A; Carli L; Signorini V; Zucchi D; Peta U; Santoni A; Raffaelli L; Mosca M
    RMD Open; 2020 Feb; 6(1):. PubMed ID: 32075876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability and validity of the Fatigue Severity Scale in Swedish for patients with systemic lupus erythematosus.
    Mattsson M; Möller B; Lundberg Ie; Gard G; Boström C
    Scand J Rheumatol; 2008; 37(4):269-77. PubMed ID: 18612927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
    Castrejón I; Tani C; Jolly M; Huang A; Mosca M
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance of patient and physician health status concerns in systemic lupus erythematosus.
    Golder V; Ooi JJY; Antony AS; Ko T; Morton S; Kandane-Rathnayake R; Morand EF; Hoi AY
    Lupus; 2018 Mar; 27(3):501-506. PubMed ID: 28764617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.